Plain-English translation of NCT06576128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a procedure called a transversus abdominis plane (TAP) block—a targeted injection that numbs nerves in the lower belly—can reduce pain during and after heart catheterization. Heart catheterization is a common procedure where doctors insert a thin tube through an artery in your groin to diagnose or treat heart problems. The trial compares standard pain management alone against standard care plus the nerve block injection.
When heart catheterization is done through the groin, patients often experience pain at the insertion site during and after the procedure. Researchers want to see if this nerve block injection can provide better pain relief and comfort, potentially improving the patient experience without adding significant risk.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive your scheduled heart catheterization procedure as planned. Half of participants will receive only the standard local anesthesia at the groin site, while the other half will also receive the nerve block injection (an ultrasound-guided injection into the abdominal area) before the procedure begins. You will be monitored during and after the procedure, and researchers will assess your pain levels and overall comfort. The study involves a single visit for your heart procedure—there are no additional appointments needed beyond your standard care.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
Turkey (Türkiye)